ADVIL MIGRAINE LIQUI-GELS Drug Patent Profile
✉ Email this page to a colleague
When do Advil Migraine Liqui-gels patents expire, and what generic alternatives are available?
Advil Migraine Liqui-gels is a drug marketed by Haleon Us Holdings and is included in one NDA.
The generic ingredient in ADVIL MIGRAINE LIQUI-GELS is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and thirty-eight suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Advil Migraine Liqui-gels
A generic version of ADVIL MIGRAINE LIQUI-GELS was approved as ibuprofen by STRIDES PHARMA on September 24th, 1986.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ADVIL MIGRAINE LIQUI-GELS?
- What are the global sales for ADVIL MIGRAINE LIQUI-GELS?
- What is Average Wholesale Price for ADVIL MIGRAINE LIQUI-GELS?
Summary for ADVIL MIGRAINE LIQUI-GELS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 207 |
| Clinical Trials: | 818 |
| Patent Applications: | 4,338 |
| DailyMed Link: | ADVIL MIGRAINE LIQUI-GELS at DailyMed |
Recent Clinical Trials for ADVIL MIGRAINE LIQUI-GELS
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Brigham and Women's Hospital | Phase 4 |
| VA Connecticut Healthcare System | Phase 1 |
| National Headache Foundation | Phase 1 |
Pharmacology for ADVIL MIGRAINE LIQUI-GELS
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
US Patents and Regulatory Information for ADVIL MIGRAINE LIQUI-GELS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Haleon Us Holdings | ADVIL MIGRAINE LIQUI-GELS | ibuprofen | CAPSULE;ORAL | 020402-002 | Mar 16, 2000 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
EU/EMA Drug Approvals for ADVIL MIGRAINE LIQUI-GELS
| Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
|---|---|---|---|---|---|---|---|---|---|
| Recordati Rare Diseases | Pedea | ibuprofen | EMEA/H/C/000549 Treatment of a haemodynamically significant patent ductus arteriosus in preterm newborn infants less than 34 weeks of gestational age. |
Authorised | no | no | no | 2004-07-28 | |
| >Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
